Eric Lindquist, MBA, is the Chief Executive Officer and Board Member at InnoSIGN and a Co-Founder of Companion Bio. They have held senior leadership roles in biotech and diagnostics, including Chief Business and Commercial Officer at Celcuity (2019–2022) and Cynvenio Biosystems (2016–2017), and Global Vice President of Oncology and Transplant Business and Commercial Development at Natera (2016–2019, after starting as a consultant in 2016). Their career spans strategic business development, partnerships, and product commercialization across organizations such as HTG Molecular Diagnostics, Abbott Laboratories/Vysis, and Johnson & Johnson/Veridex. In 2022 they co-founded Companion Bio, a therapeutics company focused on age-related diseases, and continue to contribute to its development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices